VIVO Cannabis Enters Into Research Partnership with CB2 Insights

This morning, CB2 Insights (CSE: CBII) announced it has entered into an agreement with that of Vivo Cannabis Inc (TSXV: VIVO). The joint partnership will be focused on ensuring that Vivo’s current products meet potency criteria as well as safety requirements through the use of CB2’s technology.

CB2 Insights is a contract research firm focused on cannabis. The issuer is comprised of three divisions, including clinical operations, technology and analytics, and research and development. The company’s two main programs, electronic data capture (EDC) and clinical data management system (CDMS), are used to gather and analyze data from clinical trials and client operations.  

As per the agreement, CB2 Insights will provide Vivo with analytics technology and research services in order to ensure Vivo’s products uphold Canadian cannabis regulations, as well as meet cannabis patient demands. Both of CB2’s programs are anticipated to be implemented at Vivo’s facilities as a result.

The agreement is set to take a multi-phased approach in the validation and quality assurance of current products. Conclusively, the project will be used to support the advancement of Vivo’s forthcoming cannabis products.

Vivo Cannabis is currently trading at $0.30 on the TSXV.


Information for this briefing was found via Sedar, CB2 insights and Vivo Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

CB2 Insights Conducts Early Warrant Exercise Program

CB2 Insights (CSE: CBII) is looking to generate some short term cash. The firm this...

Wednesday, December 11, 2019, 08:05:05 AM

Vivo Cannabis Reduces Outstanding Debentures From $27.1 Million To $6.6 Million

Vivo Cannabis (TSX: VIVO) has significant reduced its outstanding debt obligations through amendments to certain...

Wednesday, September 16, 2020, 09:08:13 AM

Vivo Cannabis Reduces Headcount 18%, To Sell Off Non-Core Assets

Vivo Cannabis (TSX: VIVO) is the latest cannabis issuer to “streamline operations” via significant layoffs...

Tuesday, October 20, 2020, 08:36:29 AM

Vivo Cannabis Reports Q1 Revenue Of $5.5 Million, Net Loss Of $3.5 Million

VIVO Cannabis Inc. (TSX: VIVO) last night reported its Q1 2021 financial and operating results....

Tuesday, May 18, 2021, 08:33:28 AM

Canopy Growth’s Bruce Linton Finds Himself in a Catch-22

Canopy Growth Corp’s (TSX: WEED) (NYSE: CGC) Bruce Linton came under fire yesterday across social...

Friday, June 28, 2019, 09:22:46 AM